Date Field | Doc. No. | Party | Description |
---|
Aug 4, 2020 | 3003 | board | Ex. 3003 Download |
Jun 22, 2020 | 3002 | board | Exhibit 3002 Download |
Dec 10, 2018 | 3001 | | Ex. 3001 Download |
Jul 27, 2018 | 2203 | | Kaken Exhibit 2203 Download |
Jan 5, 2018 | 2202 | | Kaken Exhibit 2202 Download |
Dec 22, 2017 | 2201 | | Kaken Exhibit 2201 Download |
Dec 22, 2017 | 2200 | | Kaken Exhibit 2200 Download |
Dec 22, 2017 | 2118 | | Kaken Exhibit 2118 Download |
Dec 22, 2017 | 2117 | | Kaken Exhibit 2117 Download |
Dec 22, 2017 | 2116 | | Kaken Exhibit 2116 (REDACTED VERSION) Download |
Jan 5, 2018 | 2113 | | Kaken Exhibit 2113 Download |
Jan 5, 2018 | 2112 | | Kaken Exhibit 2112 Download |
Jan 5, 2018 | 2111 | | Kaken Exhibit 2111 Download |
Aug 1, 2017 | 2097 | | Kaken Exhibit 2097 Download |
Aug 1, 2017 | 2096 | | Kaken Exhibit 2096 Download |
Aug 1, 2017 | 2092 | | Kaken Exhibit 2092 Download |
Aug 1, 2017 | 2091 | | Kaken Exhibit 2091 Download |
Aug 1, 2017 | 2090 | | Kaken Exhibit 2090 Download |
Aug 1, 2017 | 2089 | | Kaken Exhibit 2089 Download |
Aug 1, 2017 | 2088 | | Kaken Exhibit 2088 Download |
Aug 1, 2017 | 2087 | | Kaken Exhibit 2087 Download |
Aug 1, 2017 | 2086 | | Kaken Exhibit 2086 Download |
Aug 1, 2017 | 2085 | | Kaken Exhibit 2085 Download |
Aug 1, 2017 | 2084 | | Kaken Exhibit 2084 Download |
Aug 1, 2017 | 2083 | | Kaken Exhibit 2083 Download |
Aug 1, 2017 | 2082 | | Kaken Exhibit 2082 Download |
Aug 1, 2017 | 2081 | | Kaken Exhibit 2081 Download |
Aug 1, 2017 | 2080 | | Kaken Exhibit 2080 Download |
Aug 1, 2017 | 2079 | | Kaken Exhibit 2079 Download |
Aug 1, 2017 | 2078 | | Kaken Exhibit 2078 Download |
Aug 1, 2017 | 2077 | | Kaken Exhibit 2077 Download |
Aug 1, 2017 | 2076 | | Kaken Exhibit 2076 Download |
Aug 1, 2017 | 2075 | | Kaken Exhibit 2075 Download |
Aug 1, 2017 | 2074 | | Kaken Exhibit 2074 Download |
Aug 1, 2017 | 2073 | | Kaken Exhibit 2073 Download |
Aug 1, 2017 | 2072 | | Kaken Exhibit 2072 Download |
Aug 1, 2017 | 2071 | | Kaken Exhibit 2071 Download |
Aug 1, 2017 | 2070 | | Kaken Exhibit 2070 Download |
Aug 1, 2017 | 2069 | | Kaken Exhibit 2069 Download |
Aug 1, 2017 | 2068 | | Kaken Exhibit 2068 Download |
Aug 1, 2017 | 2067 | | Kaken Exhibit 2067 Download |
Aug 1, 2017 | 2066 | | Kaken Exhibit 2066 Download |
Aug 1, 2017 | 2065 | | Kaken Exhibit 2065 Download |
Aug 1, 2017 | 2064 | | Kaken Exhibit 2064 Download |
Aug 1, 2017 | 2063 | | Kaken Exhibit 2063 Download |
Aug 1, 2017 | 2062 | | Kaken Exhibit 2062 Download |
Aug 1, 2017 | 2060 | | Kaken Exhibit 2060 Download |
Aug 1, 2017 | 2059 | | Kaken Exhibit 2059 Download |
Aug 1, 2017 | 2058 | | Kaken Exhibit 2058 Download |
Aug 1, 2017 | 2057 | | Kaken Exhibit 2057 Download |
Aug 1, 2017 | 2056 | | Kaken Exhibit 2056 Download |
Aug 1, 2017 | 2055 | | Kaken Exhibit 2055 Download |
Aug 1, 2017 | 2054 | | Kaken Exhibit 2054 Download |
Aug 1, 2017 | 2053 | | Kaken Exhibit 2053 Download |
Aug 1, 2017 | 2052 | | Kaken Exhibit 2052 Download |
Aug 1, 2017 | 2051 | | Kaken Exhibit 2051 Download |
Aug 1, 2017 | 2050 | | Kaken Exhibit 2050 Download |
Aug 1, 2017 | 2049 | | Kaken Exhibit 2049 Download |
Aug 1, 2017 | 2048 | | Kaken Exhibit 2048 Download |
Aug 1, 2017 | 2047 | | Kaken Exhibit 2047 Download |
Aug 1, 2017 | 2046 | | Kaken Exhibit 2046 Download |
Aug 1, 2017 | 2045 | | Kaken Exhibit 2045 Download |
Aug 1, 2017 | 2044 | | Kaken Exhibit 2044 Download |
Aug 1, 2017 | 2043 | | Kaken Exhibit 2043 Download |
Aug 1, 2017 | 2042 | | Kaken Exhibit 2042 Download |
Aug 1, 2017 | 2041 | | Kaken Exhibit 2041 Download |
Aug 1, 2017 | 2040 | | Kaken Exhibit 2040 Download |
Aug 1, 2017 | 2039 | | Kaken Exhibit 2039 Download |
Aug 1, 2017 | 2038 | | Kaken Exhibit 2038 Download |
Aug 1, 2017 | 2037 | | Kaken Exhibit 2037 Download |
Aug 1, 2017 | 2036 | | Kaken Exhibit 2036 Download |
Aug 1, 2017 | 2035 | | Kaken Exhibit 2035 Download |
Aug 1, 2017 | 2034 | | Kaken Exhibit 2034 Download |
Aug 1, 2017 | 2033 | | Kaken Exhibit 2033 Download |
Aug 1, 2017 | 2032 | | Kaken Exhibit 2032 Download |
Aug 1, 2017 | 2031 | | Kaken Exhibit 2031 Download |
Aug 1, 2017 | 2030 | | Kaken Exhibit 2030 Download |
Aug 1, 2017 | 2029 | | Kaken Exhibit 2029 Download |
Aug 1, 2017 | 2028 | | Kaken Exhibit 2028 Download |
Aug 1, 2017 | 2027 | | Kaken Exhibit 2027 Download |
Aug 1, 2017 | 2026 | | Kaken Exhibit 2026 Download |
Aug 1, 2017 | 2025 | | Kaken Exhibit 2025 Download |
Aug 1, 2017 | 2024 | | Kaken Exhibit 2024 Download |
Jul 18, 2017 | 2023 | | Kaken Exhibit 2023 Download |
Feb 2, 2017 | 2022 | | Kaken Exhibit 2022 Download |
Feb 2, 2017 | 2021 | | Kaken Exhibit 2021 Download |
Feb 2, 2017 | 2020 | | Kaken Exhibit 2020 Download |
Feb 2, 2017 | 2019 | | Kaken Exhibit 2019 Download |
Feb 2, 2017 | 2018 | | Kaken Exhibit 2018 Download |
Feb 2, 2017 | 2017 | | Kaken Exhibit 2017 Download |
Feb 2, 2017 | 2016 | | Kaken Exhibit 2016 Download |
Feb 2, 2017 | 2015 | | Kaken Exhibit 2015 Download |
Feb 2, 2017 | 2014 | | Kaken Exhibit 2014 Download |
Feb 2, 2017 | 2013 | | Kaken Exhibit 2013 Download |
Feb 2, 2017 | 2012 | | Kaken Exhibit 2012 Download |
Feb 2, 2017 | 2011 | | Kaken Exhibit 2011 Download |
Feb 2, 2017 | 2010 | | Kaken Exhibit 2010 Download |
Feb 2, 2017 | 2009 | | Kaken Exhibit 2009 Download |
Feb 2, 2017 | 2008 | | Kaken Exhibit 2008 Download |
Feb 2, 2017 | 2007 | | Kaken Exhibit 2007 Download |
Feb 2, 2017 | 2006 | | Kaken Exhibit 2006 Download |
Feb 2, 2017 | 2005 | | Kaken Exhibit 2005 Download |
Feb 2, 2017 | 2004 | | Kaken Exhibit 2004 Download |
Feb 2, 2017 | 2003 | | Kaken Exhibit 2003 Download |
Feb 2, 2017 | 2002 | | Kaken Exhibit 2002 Download |
Feb 2, 2017 | 2001 | | Kaken Exhibit 2001 Download |
Jan 5, 2018 | 1672 | | Declaration of Lisa N. Phillips in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 Download |
Jan 5, 2018 | 1671 | | Declaration of John C. Staines, Jr. in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 Download |
Jan 5, 2018 | 1670 | | Declaration of Aydin H. Harston in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 Download |
Jan 5, 2018 | 1669 | | Declaration of Caitlin M. Wilmot in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 Download |
Jan 5, 2018 | 1668 | | Declaration of Aydin H. Harston in Support of Supplemental Evidence Served May 30, 2017, with attached exhibits Download |
Jan 5, 2018 | 1667 | | Prosecution History of U.S. Pat. App. No. 15,405,171 Download |
Dec 22, 2017 | 1666 | | E-mail string, initiated on August 10, 2017 Download |
Nov 1, 2017 | 1665 | | Kaken Exhibit 2115, Certificate of Translation for the Evidentiary Declaration of Motonori Miyakawa Download |
Nov 1, 2017 | 1664 | | Kaken Exhibit 2114, Evidentiary Declaration of Motonori Miyakawa Download |
Nov 1, 2017 | 1662 | | Kaken Exhibit 2106, Evidentiary Declaration of Vincent A. Thomas, CPA, CVA, CFF, ABV Download |
Nov 1, 2017 | 1661 | | Kaken Exhibit 2100, Evidentiary Declaration of Edward Shupenus Download |
Nov 1, 2017 | 1660 | | Download |
Nov 1, 2017 | 1659 | | Valeant Pharmaceuticals International, Inc. (VRX) Q2 2014 Results Earnings Call Transcript, dated July 31, 2014, Download |
Nov 1, 2017 | 1658 | | Download |
Nov 1, 2017 | 1657 | | Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations: Search results for Terbinafine Download |
Nov 1, 2017 | 1656 | | Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations: Search results for Tavaborole, Download |
Nov 1, 2017 | 1655 | | Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations: Search results for Itraconazole Download |
Nov 1, 2017 | 1654 | | Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations: Search results for Fluconazole Download |
Nov 1, 2017 | 1653 | | Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations: Search results for Efinaconazole Download |
Nov 1, 2017 | 1652 | | Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations: Search results for Ciclopirox Download |
Nov 1, 2017 | 1651 | | Consolidated Financial Results for Fiscal 2016 (Reference Data of Financial Statements for the 3Q of Fiscal 2016 Download |
Nov 1, 2017 | 1650 | | Consolidated Financial Results for Fiscal 2016 (Reference Data of Financial Statements for the 2Q of Fiscal 2016), Download |
Nov 1, 2017 | 1649 | | Consolidated Financial Results for Fiscal 2016 (Reference Data of Financial Statements Fiscal 2016 1st Quarter) Download |
Nov 1, 2017 | 1648 | | onsolidated Financial Results for Fiscal 2015 (Reference Data of Financial Statements for the 3Q of Fiscal 2015) Download |
Nov 1, 2017 | 1647 | | Consolidated Financial Results for Fiscal 2015 Download |
Nov 1, 2017 | 1646 | | Consolidated Financial Results for Fiscal 2015 Download |
Nov 1, 2017 | 1645 | | Top 200 Drugs for 2007 by Sales Download |
Nov 1, 2017 | 1644 | | Top 200 Drugs for 2006 by Sales Download |
Nov 1, 2017 | 1643 | | Top 200 Drugs for 2005 by Sales Download |
Nov 1, 2017 | 1642 | | Top 200 Drugs for 2004 by Sales Download |
Nov 1, 2017 | 1641 | | Top 200 Brand-Name Drugs by Retail Sales in 2003 Download |
Nov 1, 2017 | 1640 | | Top 200 Brand-Name Drugs by Retail Sales in 2002 Download |
Nov 1, 2017 | 1639 | | Top 200 Brand-Name Drugs by Retail Sales in 2001 Download |
Nov 1, 2017 | 1638 | | Top 200 Brand-Name Drugs by Retail Sales in 2000 Download |
Nov 1, 2017 | 1637 | | Prescription drug expenditures in 2000: The upward trend continues Download |
Nov 1, 2017 | 1636 | | Download |
Nov 1, 2017 | 1635 | | Pricing and reimbursement in U.S. pharmaceutical markets Download |
Nov 1, 2017 | 1634 | | With Valeant, Things Can Always be Worse, and the Past is Never Buried Download |
Nov 1, 2017 | 1633 | | Valeant, Woes Rising, Backs Away From Boldness to Calm Investors Download |
Nov 1, 2017 | 1632 | | Download |
Nov 1, 2017 | 1631 | | Ortho Dermatologics RX Access Program Download |
Nov 1, 2017 | 1630 | | Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2014 Download |
Nov 1, 2017 | 1629 | | A Financial Perspective on the Topical Treatment of Onychomycosis Download |
Nov 1, 2017 | 1628 | | Download |
Nov 1, 2017 | 1627 | | CVS Plans to Restrict $1,000 Toenail Fungus Drug Jublia Download |
Jan 5, 2018 | 1626 | | Exhibit 1626(a) - ¿¿¿Copay Programs¿¿¿ Increased Value to Manufacturers is Matched by Rising Criticism,¿¿¿ S. Shelly, Pharmaceutical Commerce, 9(1): 1-32 (January 15, 2014) Download |
Nov 1, 2017 | 1626 | | Download |
Nov 1, 2017 | 1625 | | Download |
Nov 1, 2017 | 1624 | | Physician Awareness of Drug Cost: A Systematic Review Download |
Nov 1, 2017 | 1623 | | An Exploratory Study to Improve Sales Operations When Selling Multiple Prescription Drugs Download |
Jan 5, 2018 | 1623 | | Download |
Nov 1, 2017 | 1622 | | Promotion and Market Share in the Proton Pump Inhibitor Market: A Case Study Download |
Nov 1, 2017 | 1621 | | The Drug Pushers Download |
Nov 1, 2017 | 1620 | | Following the Script: How Drug Reps Make Friends and Influence Doctors Download |
Jan 5, 2018 | 1619 | | Exhibit 1619(a) - ¿¿¿Physicians-Pharmaceutical Sales Representatives interactions and Conflict of Interest: Challenges and Solutions,¿¿¿ A.R. Patwardhan, The Journal of Health Care Organization, Provision, and Financing, 53:1-5 (2016) Download |
Nov 1, 2017 | 1619 | | Physicians-Pharmaceutical Sales Representatives interactions and Conflict of Interest: Challenges and Solutions Download |
Nov 1, 2017 | 1618 | | Valeant Pharmaceuticals International, Inc. Third Quarter 2014 Financial Results Conference Call Presentation, dated October 20, 2014 Download |
Nov 1, 2017 | 1617 | | Bladders, Guts and Feet: The Psychology Behind Anthropomorphic Body Parts Download |
Nov 1, 2017 | 1616 | | Direct to Consumer Advertising and Prescription Choice Download |
Nov 1, 2017 | 1615 | | Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer Advertising Download |
Nov 1, 2017 | 1614 | | Anacor Pharmaceuticals, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2015 Download |
Nov 1, 2017 | 1613 | | Anacor Pharmaceuticals Reports Third Quarter 2015 Financial Results Download |
Nov 1, 2017 | 1612 | | Valeant Pharmaceuticals International, Inc. First Quarter 2015 Financial Results Conference Call Presentation Download |
Nov 1, 2017 | 1611 | | Valeant Pharmaceuticals International, Inc. Fourth Quarter Preliminary Unaudited Financial Results 2015 Conference Call Presentation, dated March 15, 2016 Download |
Nov 1, 2017 | 1610 | | Valeant Pharmaceuticals International, Inc. 2015 Financial Guidance Conference Call Presentation, dated January 8, 2015 Download |
Nov 1, 2017 | 1609 | | Pharma is the 7th Largest Ad Category in the U.S. at $6.4 billion Last Year Download |
Nov 1, 2017 | 1608 | | Valeant Pharmaceuticals International, Inc., 2015 J.P. Morgan Healthcare Conference, dated January 13, 2015 Download |
Nov 1, 2017 | 1607 | | Hold the Valeant Applause Download |
Nov 1, 2017 | 1606 | | Secondary Considerations of Nonobviousness Analysis: The Use of Objective Indicia Following KSR v. Teleflex, 86 N.Y.U. L. Rev. 2070 Download |
Nov 1, 2017 | 1605 | | Download |
Jan 5, 2018 | 1604 | | Exhibit 1604(a) - Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2012 Download |
Nov 1, 2017 | 1604 | | Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2012 Download |
Jan 5, 2018 | 1603 | | Exhibit 1603(a) - Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2013 Download |
Nov 1, 2017 | 1603 | | Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2013 Download |
Nov 1, 2017 | 1602 | | New Drug Application 203567, Approval Letter from Julie Beitz, MD, Director, Office of Drug Evaluation III, Center for Drug Evaluation and Research to Sean Humphrey, Manager, Regulatory Affairs, Dow Pharmaceutical Sciences, Inc., dated June 6, 2014 Download |
Nov 1, 2017 | 1601 | | Returns on Research and Development for 1990s New Drug Introductions Download |
Nov 1, 2017 | 1600 | | Valeant Pharmaceuticals International, Inc. (VRX) Q4 2014 Results Earnings Call Transcript, dated February 23, 2015 Download |
Nov 1, 2017 | 1599 | | Dow Pharmaceutical Sciences Becomes Wholly Owned Subsidiary as Acquisition by Valeant Pharmaceuticals International is Completed Download |
Nov 1, 2017 | 1598 | | Valeant Pharmaceuticals (VRX) Q3 2014 Results Earnings Call Transcript Download |
Nov 1, 2017 | 1597 | | Promotional spending for prescription drugs Download |
Nov 1, 2017 | 1596 | | A Healthy Ad Market Download |
Nov 1, 2017 | 1595 | | Download |
Nov 1, 2017 | 1594 | | Pharmaceutical Super Bowl Ads Fall Flat Download |
Nov 1, 2017 | 1593 | | Valeant Pharmaceuticals International, Inc. Presentation, dated February 23, 2015 Download |
Nov 1, 2017 | 1592 | | Valeant Pharmaceuticals International, Inc. Second Quarter 2014 Financial Results Conference Call Presentation, dated July 31, 2014 Download |
Nov 1, 2017 | 1591 | | Valeant Pharmaceuticals International, Inc. Q3 2015 Financial Results Presentation Download |
Nov 1, 2017 | 1590 | | Consolidated Financial Results for Fiscal 2016 Download |
Nov 1, 2017 | 1589 | | Product Differentiation, Market Structure, and Competition Download |
Nov 1, 2017 | 1588 | | Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-Q, for the Quarterly Period Ended June 30, 2017 Download |
Jan 5, 2018 | 1588 | | Exhibit 1588(a) - Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-Q, for the Quarterly Period Ended June 30, 2017 Download |
Nov 1, 2017 | 1587 | | Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-Q, for the Quarterly Period Ended March 31, 2017 Download |
Nov 1, 2017 | 1586 | | Download |
Nov 1, 2017 | 1585 | | Download |
Nov 1, 2017 | 1584 | | Download |
Nov 1, 2017 | 1583 | | Download |
Nov 1, 2017 | 1582 | | Download |
Nov 1, 2017 | 1581 | | Download |
Nov 1, 2017 | 1580 | | Inside the Secret World of Drug Company Rebates Download |
Nov 1, 2017 | 1579 | | Valeant Pharmaceuticals International, Inc., Jefferies Autumn 2015 Global Healthcare Conference Download |
Nov 1, 2017 | 1578 | | Valeant Pharmaceuticals International, Inc. Second Quarter 2016 Conference Call Presentation Download |
Nov 1, 2017 | 1577 | | Valeant Pharmaceuticals International, Script Tracker Download |
Nov 1, 2017 | 1576 | | Download |
Nov 1, 2017 | 1575 | | Valeant: An Enduring Engine for Growth Download |
Nov 1, 2017 | 1574 | | Valeant Pharmaceuticals International, Inc. 2Q 17 Financial Results Presentation Download |
Nov 1, 2017 | 1573 | | Valeant Pharmaceuticals International, Inc. 1Q 2017 Financial Results Conference Call Presentation Download |
Nov 1, 2017 | 1572 | | Valeant Pharmaceuticals International, Inc. Fourth Quarter and Full Year 2015 Supplemental Information Presentation, dated April 29, 2016 Download |
Nov 1, 2017 | 1571 | | Valeant Pharmaceuticals International, Inc. First Quarter 2016 Conference Call Presentation, dated June 7, 2016 Download |
Nov 1, 2017 | 1570 | | Valeant Pharmaceuticals International, Inc. Q2 2015 Financial Results Presentation, dated July 23, 2015 Download |
Nov 1, 2017 | 1569 | | Thomas Reuters StreetEvents, Edited Transcript, VRX.TO - Q3 2016 Valeant Pharmaceuticals International Inc. Earnings Call Download |
Nov 1, 2017 | 1568 | | Prescription Drug Pricing in the Private Sector: a CBO Paper Download |
Nov 1, 2017 | 1567 | | The life cycle of a pharmaceutical brand Download |
Nov 1, 2017 | 1566 | | 100 Best-Selling, Most Prescribed Branded Drugs through March Download |
Nov 1, 2017 | 1565 | | Health Insurance and the Growth in Pharmaceutical Expenditures Download |
Nov 1, 2017 | 1564 | | Pharmaceutical Industry Antitrust Handbook Download |
Nov 1, 2017 | 1563 | | How Increased Competition From Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry: a CBO Study Download |
Nov 1, 2017 | 1562 | | Download |
Nov 1, 2017 | 1561 | | A Realistic Approach to the Obviousness of Inventions Download |
Nov 1, 2017 | 1560 | | Two are Charged in Fraud and Kickback Scheme Against Valeant Pharmaceuticals Download |
Nov 1, 2017 | 1559 | | Valeant Ex-CEO, Ex-CFO Are a Focus of U.S. Criminal Probe Download |
Nov 1, 2017 | 1558 | | Valeant Sold Some Drugs Twice Download |
Nov 1, 2017 | 1557 | | Mike Pearson is on His Way Out of Valeant, Former CFO Refuses to Leave Board Download |
Nov 1, 2017 | 1556 | | Valeant Announces CEO Succession Plan And Changes To Board Of Directors; Provides Accounting And Financial Reporting Update Download |
Nov 1, 2017 | 1555 | | Valeant Under Investigation by SEC Download |
Jan 5, 2018 | 1554 | | Exhibit 1554(a) - Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2016 Download |
Nov 1, 2017 | 1554 | | Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2016 Download |
Nov 1, 2017 | 1553 | | Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2015 Download |
Jan 5, 2018 | 1553 | | Exhibit 1553(a) - Valeant Pharmaceuticals International, Inc., U.S. Securities and Exchange Commission Form 10-K, for the Fiscal Year Ended December 31, 2015 Download |
Nov 1, 2017 | 1552 | | Valeant to Terminate Relationship with Philidor Download |
Nov 1, 2017 | 1551 | | Yahoo Finance, Valeant Pharmaceuticals International, Inc., Stock Price Historical Values (Daily), dated from October 1, 2015 through December 31, 2015 Download |
Nov 1, 2017 | 1550 | | Download |
Nov 1, 2017 | 1549 | | CVS, Express Scripts, UnitedHealth Group Cut Off Philidor, Pharmacy Used by Valeant Download |
Nov 1, 2017 | 1548 | | Download |
Jan 5, 2018 | 1547 | | Exhibit 1547(a) - Citron Research, Valeant: Could this be the Pharmaceutical Enron?, For the Rest of the Story, Click Here Download |
Nov 1, 2017 | 1547 | | Valeant: Could this be the Pharmaceutical Enron Download |
Nov 1, 2017 | 1546 | | Valeant Pharmaceuticals Under Investigation by Federal Prosecutors Download |
Nov 1, 2017 | 1545 | | Valeant Slumps Again After Rebutting Critical Report Download |
Nov 1, 2017 | 1544 | | The King¿¿¿s Gambit: Valeant¿¿¿s Big Secret Download |
Jan 5, 2018 | 1544 | | Download |
Jan 5, 2018 | 1543 | | Exhibit 1543(a) - ¿¿¿Is Walgreens Valeant¿¿¿s New Philidor?¿¿¿ D. A. Hussar, The Pharmacist Activist, vol. 11, no. 2 (February 2016) Download |
Nov 1, 2017 | 1543 | | Download |
Nov 1, 2017 | 1542 | | Suit Alleges Valeant Ran Secret Prescription Refill Scam Download |
Nov 1, 2017 | 1541 | | Valeant Shares Fall After Sales and Earnings Targets Cut Download |
Nov 1, 2017 | 1540 | | Download |
Nov 1, 2017 | 1539 | | Download |
Nov 1, 2017 | 1538 | | Curing the Prior Authorization Headache Download |
Nov 1, 2017 | 1537 | | Adventures in Prior Authorization Download |
Nov 1, 2017 | 1536 | | Download |
Jan 5, 2018 | 1535 | | Exhibit 1535(a) - "Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive?¿¿¿ P.M. Danzon, International Journal of the Economics of Business, 22(2):245-261 (2015). Download |
Nov 1, 2017 | 1535 | | Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive Download |
Nov 1, 2017 | 1534 | | Valeant Plunges on Report U.S. Attorney Pursuing Criminal Charges against the Company Download |
Nov 1, 2017 | 1533 | | Download |
Nov 1, 2017 | 1532 | | U.S. Drug Benefit Managers Clamp Down on Specialty Pharmacies Download |
Nov 1, 2017 | 1531 | | Drug Makers Sidestep Barriers on Pricing Download |
Nov 1, 2017 | 1530 | | Valeant, Philidor RX, and the Uninformed Attack on Specialty Pharmacy Download |
Nov 1, 2017 | 1529 | | Thomas Reuters StreetEvents, Edited Transcript, VRX.TO - Q3 2015 Valeant Pharmaceuticals International Inc. Earnings Call Download |
Nov 1, 2017 | 1528 | | Valeant Under Criminal Investigation Download |
Nov 1, 2017 | 1527 | | Valeant and Pharmacy More Intertwined than Thought Download |
Nov 1, 2017 | 1526 | | Valeant Pharmaceuticals International, Inc., Investor Conference Call Presentation, October 26, 2015 Download |
Nov 1, 2017 | 1525 | | Download |
Nov 1, 2017 | 1524 | | Leaked Documents Shed Light on the Defunct Pharmacy that Brought Valeant to its Knees Download |
Nov 1, 2017 | 1523 | | Kaken Research & Development Division: R&D Pipeline Download |
Nov 1, 2017 | 1522 | | Antifungal drugs for onychomycosis: efficacy, safety, and mechanisms of action Download |
Jan 5, 2018 | 1522 | | Exhibit 1522(a) - Theodore Rosen et al., Seminars in Cutaneous Medicine and Surgery: Onychomycosis- Diagnosis, Treatment, and Prevention Strategies (Supp. 3), 35 (3S): S51- S55 (2016) Download |
Nov 1, 2017 | 1521 | | Download |
Nov 1, 2017 | 1520 | | Label for Terbinafine Hydrochloride Cream, 1% Download |
Nov 1, 2017 | 1519 | | Download |
Nov 1, 2017 | 1518 | | Risk factors and comorbidities for onychomycosis: implications for treatment with topical therapy Download |
Nov 1, 2017 | 1517 | | Download |
Nov 1, 2017 | 1516 | | Download |
Nov 1, 2017 | 1515 | | Download |
Nov 1, 2017 | 1514 | | Pharmacokinetics of antimycotics with emphasis on local treatment Download |
Jan 5, 2018 | 1513 | | Exhibit 1513(a) - Tadashi Arika et al., Nishi Nihon Journal of Dermatology, 52 (3): 545-549 (1990) Download |
Nov 1, 2017 | 1513 | | Antibacterial activity of topical antifungal agent in the infected sites- study- skin permeability and absorption to horny materials Download |
Nov 1, 2017 | 1512 | | Dermatologic conditions of the foot Download |
Nov 1, 2017 | 1511 | | Download |
Nov 1, 2017 | 1510 | | Download |
Nov 1, 2017 | 1509 | | Download |
Nov 1, 2017 | 1508 | | Deposition Transcript of Dr. Boni E. Elewski Download |
Nov 1, 2017 | 1507 | | PUBLIC VERSION Deposition Transcript of Vincent A. Thomas Download |
Nov 1, 2017 | 1506 | | PUBLIC VERSION Deposition Transcript of Dr. Yoshiyuki Tatsumi Download |
Nov 1, 2017 | 1505 | | U.S. Pat. No. 5,962,476 to Naito et al Download |
Nov 1, 2017 | 1504 | | Meeting Minutes for IND 77732, Division of Dermatology and Dental Products: Office of Drug Evaluation III Download |
Nov 1, 2017 | 1503 | | Guidelines for treatment of onychomycosis Download |
Nov 1, 2017 | 1502 | | Trends in the management of cutaneous fungal infections Download |
Nov 1, 2017 | 1501 | | Onychomycosis Download |
Nov 1, 2017 | 1500 | | Update on the management of onychomycosis: highlights of the third annual international summit on cutaneous antifungal therapy Download |
Jun 23, 2017 | 1047 | | Reissue Application No. 15/405,171, Preliminary
Amendment and Remarks, dated 1/12/2017 Download |
Nov 2, 2016 | 1046 | | Acrux DDS Pty Ltd. Corporate Website Download |
Nov 2, 2016 | 1045 | | Acrux DDS Pty Ltd. Corporate Website Download |
Nov 2, 2016 | 1044 | | Declaration of Jeff Karr Download |
Nov 2, 2016 | 1043 | | Jublia Package Insert Download |
Nov 2, 2016 | 1042 | | Walters, K.A., J Pharm Pharmacol, 37: 771-775 (1985) Download |
Nov 2, 2016 | 1041 | | Walters, K.A., J Pharm Pharmacol, 37: 498-499 (1985) Download |
Nov 2, 2016 | 1040 | | Walters, K.A., J Pharm Pharmacol 35: 28-33 (1983) Download |
Nov 2, 2016 | 1039 | | Walters, K.A., J Invest Dermatol, 76: 76-79 (1981) Download |
Nov 2, 2016 | 1038 | | Spruit, D., J Invest Dermatol, 56(5): 359-361 (1971) Download |
Nov 2, 2016 | 1037 | | Haria, M. and Bryson, H.M., Drugs, 49(1): 103-120 (1995) Download |
Nov 2, 2016 | 1036 | | Buck, D.S. et al., The Journal of Family Practice, 38(6): 601-605 (1994) Download |
Nov 2, 2016 | 1035 | | Vanderdonckt, J., et al., Mykosen, 19(7):251-256 (1975) Download |
Nov 2, 2016 | 1034 | | J. of the American Academy of Dermatology, 35:3(2): S26-S30 (1996) Download |
Nov 2, 2016 | 1033 | | J. of the American Academy of Dermatology, 40 (Suppl):S21¿¿¿6 (1999) Download |
Nov 2, 2016 | 1032 | | Aly, R., J. Am. Acad. Dermatol., 31:S21¿¿¿S25 (1994) Download |
Nov 2, 2016 | 1031 | | Summerbell, R.C., Dermatology, 194 (Supp. 1): 32-36 (1997) Download |
Nov 2, 2016 | 1030 | | J. of the European Academy of Dermatology and Venereology 4 (Supp. 1)(1995) Download |
Nov 2, 2016 | 1029 | | Hay, R.J., Journal of Antimicrobial Chemotherapy 20: 1-5 (1987) Download |
Nov 2, 2016 | 1028 | | Baden H.P., et al., Biochim Biophys Acta 322:269¿¿¿278 (1973) Download |
Nov 2, 2016 | 1027 | | Burch, G.E., Arch Derm Syphilol 53: 39-41 (1946) Download |
Nov 2, 2016 | 1026 | | Niewerth, M., Drugs 58(2):283-296 (1999) Download |
Nov 2, 2016 | 1025 | | Heine, C. AdWeek. (Jan. 27, 2015) Download |
Nov 2, 2016 | 1024 | | Kobayashi Y. et al., Chem Pharm Bull 46: 1797- 1802 (1998) Download |
Nov 2, 2016 | 1023 | | Mertin, D., Journal of Pharmacy and Pharmacology, 49(9): 866-872 (1997) Download |
Nov 2, 2016 | 1022 | | Mertin, D., Journal of Pharmacy and Pharmacology, 49(3): 241-245 (1997) Download |
Nov 2, 2016 | 1021 | | Mertin, D., Journal of Pharmacy and Pharmacology, 49(1): 30-34 (1997) Download |
Nov 2, 2016 | 1020 | | Quintanar- Guerrero, D. et al., Drug Dev Ind Pharm, 24: 685-690 (1998) Download |
Nov 2, 2016 | 1019 | | van Hoogdalem, E.J. et al., Eur J Pharm Sci 5: 119-127 (1997) Download |
Nov 2, 2016 | 1018 | | Franz, T.J., Dermatol, 184(Suppl 1): 18-20 (1992) Download |
Nov 2, 2016 | 1017 | | Ceschin-Roques C.G., et al., Skin Pharmacol, 4: 89-94 (1991) Download |
Nov 2, 2016 | 1016 | | Stuttgen, G. and Bauer, E., Mycoses, 25(2): 74-80 (1992) Download |
Nov 2, 2016 | 1015 | | Kaken Abstracts Download |
Nov 2, 2016 | 1014 | | Hay, R.J., et al., Clinical and Experimental Dermatology, 10:111-115 (1985) Download |
Nov 2, 2016 | 1013 | | U.S. Pat. No. 5,391,367 Download |
Nov 2, 2016 | 1012 | | Ogura, H. et al., Chem. Pharm. Bull, 47(10) 1417-1425 (1999) Download |
Nov 2, 2016 | 1011 | | Certified English Translation of Japanese Pat. App. Pub. No. 10- 226639 Download |
Nov 2, 2016 | 1010 | | Publication of PCT/JP00/04617 Download |
Nov 2, 2016 | 1009 | | Comparison between the Priority Document Download |
Nov 2, 2016 | 1008 | | U.S. Pat. No. 5,716,969 Download |
Nov 2, 2016 | 1007 | | U.S. Pat. No. 5,620,994 Download |
Nov 2, 2016 | 1006 | | Prosecution History of U.S. Pat. No. 7,214,506 Download |
Nov 2, 2016 | 1005 | | Declaration of Kenneth Walters Download |
Nov 2, 2016 | 1004 | | Orange Book Excerpt for Valeant¿¿¿s Jublia Download |
Nov 2, 2016 | 1003 | | Press Release Download |
Nov 2, 2016 | 1002 | | Certified English Translation of Japanese Pat. App. No. 11/214369 Download |
Nov 2, 2016 | 1001 | | U.S. Pat. No. 7,214,506 Download |
Apr 28, 2021 | 116 | board | Decision Patent Owner's Motion to Expunge Confidential Information Download |
Feb 24, 2021 | 115 | patent_own | Patent Owner's Motion to Expunge Download |
Jan 8, 2021 | 114 | board | Download |
Nov 12, 2020 | 113 | patent_own | Patent Owner's Updated Exhibit List as of November 12, 2020 Download |
Nov 12, 2020 | 112 | patent_own | Joint Motion to Terminate Proceeding and Request to Treat Settlement Agreement as Business Confidential Information and be Kept Separate Download |
Aug 11, 2020 | 111 | petitioner | Petitioner Argentum's Sur-Reply ISO Opposition to Motion to Terminate Download |
Aug 4, 2020 | 110 | board | Order Granting Sur-Reply for Motion to Terminate Download |
Aug 2, 2020 | 108 | patent_own | Reply Brief In Support Of Joint Motion To Terminate Proceeding And Request To Treat Settlement Agreement As Business Confidential Information And Be Kept Separate Download |
Jul 27, 2020 | 107 | petitioner | Petitioner Argentum's Opposition to Joint Motion to Terminate Proceeding Download |
Jun 22, 2020 | 106 | board | Conduct of the Proceeding Download |
May 13, 2020 | 105 | | Joint Motion to Terminate Proceeding and Request to Treat Settlement Agreement as Business Confidential Information and Be Kept Separate Download |
Mar 29, 2019 | 104 | | Order Lifting Reissue Stay Download |
Mar 29, 2019 | 103 | | Order Lifting Reissue Stay Download |
Jan 16, 2019 | 102 | | Patent Owner's Seventh Updated Mandatory Notices Download |
Dec 21, 2018 | 101 | | Conduct of the Proceeding
37 C.F.R. sec. 42.5 Download |
Dec 21, 2018 | 100 | | Patent Owner¿¿¿s Unopposed Motion for
Pro Hac Vice Admission of William A. Rakoczy
37 C.F.R. sec. 42.10 Download |
Dec 21, 2018 | 99 | | Patent Owner¿¿¿s Unopposed Motion for
Pro Hac Vice Admission of Joseph T. Jaros
37 C.F.R. sec. 42.10 Download |
Dec 10, 2018 | 98 | | Notification of Receipt of POP Request Download |
Dec 6, 2018 | 97 | | Patent Owner's Sixth Updated Mandatory Notices Download |
Sep 25, 2018 | 96 | | DECLARATION OF JOSEPH T JAROS IN SUPPORT OF MOTION FOR PRO HAC ADMISSION Download |
Sep 25, 2018 | 95 | | DECLARATION OF JOSEPH T. JAROS IN SUPPORT OF MOTION FOR PRO HAC ADMISSION Download |
Sep 25, 2018 | 94 | | ACRUX'S UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF
WILLIAM A. RAKOCZY Download |
Sep 25, 2018 | 93 | | ACRUX'S UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF JOSEPH T. JAROS Download |
Sep 25, 2018 | 92 | | DECLARATION OF WILLIAM A RAKOCZY IN SUPPORT OF MOTION FOR PRO HAC ADMISSION Download |
Sep 19, 2018 | 91 | | Decision - 37 C.F.R. 42.10 Download |
Sep 18, 2018 | 90 | | ACRUX'S UPDATED MANDATORY NOTICES Download |
Aug 28, 2018 | 89 | | ACRUX'S UNOPPOSED MOTION TO WITHDRAW COUNSEL AND SUBSTITUTE NEW COUNSEL Download |
Aug 28, 2018 | 88 | | ACRUX'S REVOCATION OF POWER OF ATTORNEY AND NEW POWER OF ATTORNEY PURSUANT TO 37 C.F.R. ¿¿ 42.10(b) Download |
Aug 14, 2018 | 87 | | Patent Owner's Fifth Updated Mandatory Notices Download |
Aug 7, 2018 | 86 | | Patent Owner's Notice of Appeal Download |
Jul 27, 2018 | 85 | | Patent Owner's Updated Exhibit List Download |
Jul 27, 2018 | 84 | | Patent Owner's Request for Rehearing Under 37 C.F.R. 42.71(d), and for an Expanded Panel Download |
Jul 23, 2018 | 83 | | Patent Owner's Motion to Preserve the Record Download |
Jun 11, 2018 | 82 | | ERRATA Download |
Jun 6, 2018 | 81 | | Decision Motions to Strike and to Exclude Download |
Jun 6, 2018 | 80 | | Final Written Decision Download |
Jun 6, 2018 | 79 | | Decision Motions to Seal Download |
Apr 11, 2018 | 78 | | Hearing Transcript Download |
Jan 12, 2018 | 77 | | PETITIONERS¿¿¿ MOTION TO SEAL Download |
Jan 12, 2018 | 76 | | Patent Owner's Reply in Support of its Motion to Exclude Download |
Jan 12, 2018 | 75 | | PUBLIC VERSION - PETITIONERS¿¿¿ REPLY IN SUPPORT OF THEIR MOTION TO EXCLUDE UNDER 37 C.F.R. ¿¿ 42.64(c) Download |
Jan 12, 2018 | 73 | | Trial Order Download |
Jan 5, 2018 | 72 | | Patent Owner's Motion to Seal Patent Owner's Opposition to Petitioners' Motion to Exclude Evidence Download |
Jan 5, 2018 | 71 | | Patent Owner's Updated Exhibit List Download |
Jan 5, 2018 | 70 | | Patent Owner's Opposition to Petitioners' Motion to Exclude Evidence Submitted by Patent Owner under 37 C.F.R. 42.64(C) (REDACTED VERSION) Download |
Jan 5, 2018 | 68 | | PETITIONERS UPDATED EXHIBIT LIST - (as of January 5, 2018) Download |
Jan 5, 2018 | 67 | | PETITIONERS¿¿¿ RESPONSE TO PATENT OWNER¿¿¿S MOTION FOR OBSERVATIONS ON THE CROSS-EXAMINATION OF DR. JEFFREY M. WEINBERG Download |
Jan 5, 2018 | 66 | | PETITIONERS¿¿¿ RESPONSE TO PATENT OWNER¿¿¿S MOTION FOR OBSERVATIONS ON THE CROSS-EXAMINATION OF DR. KENNETH A. WALTERS Download |
Jan 5, 2018 | 65 | | PUBLIC VERSION - PETITIONERS¿¿¿ RESPONSE TO PATENT OWNER¿¿¿S MOTION
FOR OBSERVATIONS ON THE CROSS-EXAMINATION OF JOHN C. STAINES, JR. Download |
Jan 5, 2018 | 63 | | PETITIONERS¿¿¿ OPPOSITION TO PATENT OWNER¿¿¿S MOTION TO EXCLUDE UNDER 37 C.F.R. ¿¿ 42.64(c) Download |
Jan 5, 2018 | 62 | | PETITIONERS¿¿¿ MOTION TO SEAL Download |
Dec 22, 2017 | 61 | | Patent Owner's Request for Oral Hearing Download |
Dec 22, 2017 | 60 | | Patent Owner's Updated Exhibit List Download |
Dec 22, 2017 | 59 | | Patent Owner's Motion to Seal Exhibit 2116 Download |
Dec 22, 2017 | 58 | | Patent Owner's Motion to Exclude Under 37 C.F.R. 42.64(C) Download |
Dec 22, 2017 | 57 | | Patent Owner's Motion for Observations on the Cross-Examination of Jeffrey M. Weinberg, M.D. Download |
Dec 22, 2017 | 56 | | Patent Owner's Motion for Observations on the Cross-Examination of Kenneth A. Walters Download |
Dec 22, 2017 | 55 | | Patent Owner's Motion for Observations on the Cross-Examination of John C. Staines, Jr. Download |
Dec 22, 2017 | 54 | | PETITIONERS¿¿¿ REQUEST FOR ORAL ARGUMENT PURSUANT TO 37 C.F.R. ¿¿ 42.70(a) Download |
Dec 22, 2017 | 53 | | PETITIONER'S UPDATED EXHIBIT LIST Download |
Dec 22, 2017 | 51 | | PUBLIC VERSION - PETITIONERS¿¿¿ MOTION TO EXCLUDE EVIDENCE SUBMITTED BY PATENT OWNER UNDER 37 C.F.R. ¿¿ 42.64(c) Download |
Dec 22, 2017 | 50 | | PETITIONERS¿¿¿ MOTION TO SEAL Download |
Dec 13, 2017 | 49 | | PETITIONERS¿¿¿ OBJECTIONS TO EVIDENCE SUBMITTED DURING THE DEPOSITIONS OF KENNETH A. WALTERS, Ph.D. AND JEFFREY M. WEINBERG, M.D. PURSUANT TO 37 C.F.R. ¿¿ 42.64 Download |
Dec 6, 2017 | 48 | | PETITIONERS¿¿¿ RESPONSE TO PATENT OWNER¿¿¿S MOTION TO STRIKE Download |
Dec 6, 2017 | 47 | | PETITIONERS¿¿¿ RESPONSE TO PATENT OWNER¿¿¿S MOTION TO STRIKE Download |
Nov 27, 2017 | 46 | | Patent Owner's Motion to Strike Download |
Nov 27, 2017 | 45 | | PETITIONER¿¿¿S UPDATED NOTICE OF COUNSEL UNDER 37 C.F.R. ¿¿ 42.8 Download |
Nov 21, 2017 | 44 | | Notice of Deposition of Kenneth A. Walters, Ph.D. Download |
Nov 21, 2017 | 43 | | Order Conduct of the Proceeding Download |
Nov 20, 2017 | 42 | | Notice of Deposition of Jeffrey M. Weinberg, M.D. Download |
Nov 20, 2017 | 41 | | Notice of Deposition of John C. Staines, Jr. Download |
Nov 13, 2017 | 40 | | COPY of Order Joining IPR2017-01429 with IPR2017-00190 Download |
Nov 8, 2017 | 39 | | Patent Owner's Objections to Evidence Submitted with Petitioner's Reply Download |
Nov 1, 2017 | 38 | | PETITIONERS UPDATED EXHIBIT LIST Download |
Nov 1, 2017 | 37 | | Petitioners Reply to Patent Owners Response Download |
Nov 1, 2017 | 36 | | Download |
Sep 27, 2017 | 35 | | Notice of Deposition of B. E. Elewski Download |
Sep 27, 2017 | 34 | | Patent Owners Motion for Pro Hac Vice Admission of Barbara R. Rudolph, Ph.D., and Petitioners Motion for Pro Hac Vice Admission of Lisa N. Phillips 37 C.F.R. sec 42.10 Download |
Sep 26, 2017 | 33 | | NOTICE OF DEPOSITION OF VINCENT A THOMAS Download |
Sep 26, 2017 | 32 | | NOTICE OF DEPOSITION OF YOSHIYUKI TATSUMI, PH.D Download |
Aug 31, 2017 | 31 | | Order - Stay of Reissue Application No. 15/405,171 Download |
Aug 23, 2017 | 30 | | Declaration of Lisa N. Phillips Download |
Aug 23, 2017 | 29 | | Petitioners' Unopposed Motion For Hac Vice Admission of Lisa N. Phillips Download |
Aug 8, 2017 | 28 | | PETITIONERS¿¿¿ OBJECTIONS TO EVIDENCE SUBMITTED WITH PATENT OWNER¿¿¿S RESPONSE PURSUANT TO 37 C.F.R. ¿¿ 42.64(b)(1) Download |
Aug 1, 2017 | 27 | | Patent Owner's Response Download |
Aug 1, 2017 | 26 | | Patent Owner's Updated Exhibit List Download |
Aug 1, 2017 | 25 | | Patent Owners' Motion to Seal Exhibits 2093-2095, 2098, and 2099 Download |
Jul 18, 2017 | 24 | | Patent Owner's Updated Exhibit List Download |
Jul 18, 2017 | 23 | | Patent Owner's Unopposed Motion For Pro Hac Vice Admission of Barbara R. Rudolph, Ph.D. Download |
Jul 8, 2017 | 22 | | PETITIONERS¿¿¿ REPLY TO PATENT OWNERS¿¿¿ OPPOSITION TO PETITIONERS¿¿¿ MOTION TO STAY REISSUE PROCEEDING Download |
Jul 3, 2017 | 21 | | Patent Owner's Opposition to Petitioner's Motion to Stay Reissue Proceeding Download |
Jun 29, 2017 | 20 | | Notice of Deposition of Kenneth A. Walters, Ph.D. Download |
Jun 23, 2017 | 19 | | Petitioners' Motion to Stay Related Reissue Proceedings Download |
Jun 23, 2017 | 18 | | Patent Owner's Fourth Updated Mandatory Notices Download |
Jun 16, 2017 | 17 | | Petitioner's Submission of Transcript of June 13, 2017 Conference Call Download |
Jun 14, 2017 | 16 | | ORDER Conduct of the Proceeding Download |
May 15, 2017 | 15 | | Patent Owner's Objections to Evidence Download |
May 15, 2017 | 14 | | PETITIONERS¿¿¿ OBJECTIONS TO EVIDENCE SUBMITTED WITH PATENT OWNER¿¿¿S PRELIMINARY RESPONSE PURSUANT TO 37 C.F.R. ¿¿ 42.64(b)(1) Download |
May 1, 2017 | 13 | | SCHEDULING ORDER Download |
May 1, 2017 | 12 | | DECISION - Institution of Inter Partes Review Download |
Mar 1, 2017 | 11 | | Conduct of the Proceeding Download |
Feb 24, 2017 | 10 | | Petitioners Submission of Transcript of February 21, 2017 Conference Call Download |
Feb 24, 2017 | 9 | | Patent Owner's Updated Mandatory Notices Download |
Feb 2, 2017 | 8 | | Patent Owner's Preliminary Response Download |
Feb 2, 2017 | 7 | | Patent Owner's Updated Mandatory Notices Download |
Dec 27, 2016 | 6 | | Patent Owner's Updated Mandatory Notices Download |
Dec 12, 2016 | 5 | | Patent Owner's Power of Attorney Download |
Dec 12, 2016 | 4 | | Patent Owner's Mandatory Notices Download |
Nov 16, 2016 | 3 | | Notice of Accord Filing Date Download |
Nov 2, 2016 | 2 | | Power of Attorney Download |
Nov 2, 2016 | 1 | | PETITION to Institute an Inter Partes Review of U.S. Patent No. 7,214,506 Download |